Rich Pharmaceuticals
9595 Wilshire Boulivard
Suite 900
Beverly Hills
California
90045
United States
Tel: 424-230-7001
Fax: 424-230-7003
Website: http://www.richpharmaceuticals.com/
Email: info@richpharmaceuticals.com
33 articles about Rich Pharmaceuticals
-
Rich Pharma Announces Collaboration Agreement To Support The Development Of Treatments For Parkinson's Disease
7/18/2017
-
Rich Pharma Announces Principal Doctor For Clinical Trials
6/23/2017
-
Rich Pharma Announces Institutional Review Board Submission
6/8/2017
-
Rich Pharma Announces Clinical Site In Thailand
6/2/2017
-
Rich Pharma' Division Canncodex Releases List Of Conditional Use Permits Issued In California To Medicinal Cannabis Businesses
5/10/2017
-
Rich Pharma Welcomes New Board Member
4/11/2017
-
Rich Pharma Announces Industry Veteran To Join CannCodex
4/6/2017
-
Rich Pharma To Launch CannCodex, Marking Its Entry Into Medicinal Cannabis Industry
3/22/2017
-
Rich Pharma Attracts New Financing Package With GHS Investments, LLC
2/28/2017
-
Rich Pharma Announces Quarterly Milestones
9/27/2016
-
Rich Pharma Retains Theradex Systems To Help Advance Its Hodgkin's Lymphoma Indication
6/21/2016
-
Rich Pharma Retains Contract Research Organization, CMIC, To Manage Upcoming Phase 1/2 Clinical Trial For Its Acute Myelocytic Leukemia (AML) And Myelodysplastic Syndrome (MDS) Drug In Thailand
4/4/2016
-
Rich Pharma Further Extends CRO Agreement With Theradex Systems To Manage Upcoming Phase 1/2 Clinical Trial For Its Acute Myelocytic Leukemia (AML) And Myelodysplastic Syndrome (MDS) Drug In The United States
3/30/2016
-
Rich Pharma Highlights Goals And Objectives For 2016
2/16/2016
-
Rich Pharma Announces Reverse Split
2/10/2016
-
Rich Pharma Receives FDA Approval For A Phase 1/2 Study In AML & MDS
12/28/2015
-
Rich Pharma Announces Additional Submission To The FDA
11/23/2015
-
Rich Pharmaceuticals Retains Theradex® To Finalize Investigational New Drug Application And Initiate Next Phases Of Clinical Trials
10/7/2015
-
Rich Pharmaceuticals Appoints Richard Salvador, Ph.D., Research & Development Expert, To Board Of Directors
8/11/2015
-
Rich Pharmaceuticals Announces Letter Of Intent With Faculty Of Medicine At Khon Kaen University To Conduct Acute Myelocytic Leukemia Clinical Trials
3/24/2015